Clinical Trials in North Carolina

Showing 14641-14660 of 17,526 trials

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

NCT00699153

Evaluation of the clinical safety and efficacy of loteprednol etabonate in an ophthalmic base, when compared to vehicle for the treatment of inflammation following cataract surgery.

Ocular Inflammation

Bausch & Lomb Incorporated400 participantsStarted Jun 2008

High Point, North Carolina, United States

COMPLETED31 miles

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca1,297 participantsStarted Sep 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tucson, Arizona, United States +104 more locations

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Find Trials by Condition in North Carolina

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

The BRILLIANT Study

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Phase IIIB Subcutaneous Abatacept Monotherapy Study

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme